Department of Pharmacology and Therapeutics, Sefako Makgatho Health Science University, Pretoria, South Africa. Email:
Department of Clinical Pharmacology, School of Medicine, Dr George Mukhari Academic Hospital, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
Cardiovasc J Afr. 2024;35(1):7-11. doi: 10.5830/CVJA-2022-064. Epub 2023 Feb 13.
Increased arterial stiffness is a determinant of cardiovascular mortality and an independent marker of cardiovascular disease. The objective of this study was to asses arterial elasticity by determination of pulse-wave velocity (PWV) and augmentation index (Aix) in obese black patients.
PWV and Aix were assessed non-invasively using the AtCor SphygmoCor system (AtCor Medical, Inc, Sydney, Australia). The study participants were divided into four groups; healthy volunteers (HV) ( = 29), patients with concomitant diseases but normal body mass index (Nd) ( = 23), obese patients without concomitant diseases (OB) ( = 29) and obese patients with concomitant diseases (OBd) ( = 29).
The difference in the mean levels of PWV was statistically significant in the obese group with and without concomitant disease. The PWV in the OB group (7.9 ± 2.9 m/s) and in the OBd group (9.2 ± 4.4 m/s) was, respectively, 19.7 and 33.3% higher than in the HV group (6.6 ± 2.1 m/s). PWV was directly correlated with age, glycated haemoglobin level, aortic systolic blood pressure and heart rate. The risk of cardiovascular diseases in the obese patient without additional diseases was increased by 50.7%. The presence of concomitant diseases (type 2 diabetes mellitus and hypertension) in addition to obesity increased arterial stiffness by a further 11.4% and therefore also increased the risk of cardiovascular diseases by a further 35.1%. Aix was increased in the OBd and Nd groups by 8.2 and 16.5%, respectively, however the increase was not statistically significant. Aix was directly correlated with age, heart rate and aortic systolic blood pressure.
The obese black patients had a higher PWV, indicating increase in arterial stiffness and therefore a higher risk for cardiovascular disease. In addition, aging, increased blood pressure and type 2 diabetes mellitus contributed further to arterial stiffening in these obese patients.
动脉僵硬度增加是心血管死亡率的决定因素,也是心血管疾病的独立标志物。本研究的目的是通过测定脉搏波速度(PWV)和增强指数(Aix)来评估肥胖黑人患者的动脉弹性。
使用 AtCor SphygmoCor 系统(AtCor Medical,Inc,悉尼,澳大利亚)无创性地评估 PWV 和 Aix。研究参与者分为四组:健康志愿者(HV)(=29 人)、伴有疾病但正常体重指数的患者(Nd)(=23 人)、无伴发疾病的肥胖患者(OB)(=29 人)和伴有伴发疾病的肥胖患者(OBd)(=29 人)。
肥胖伴或不伴伴发疾病组的平均 PWV 水平差异有统计学意义。OB 组(7.9±2.9 m/s)和 OBd 组(9.2±4.4 m/s)的 PWV 分别比 HV 组(6.6±2.1 m/s)高 19.7%和 33.3%。PWV 与年龄、糖化血红蛋白水平、主动脉收缩压和心率直接相关。无其他疾病的肥胖患者患心血管疾病的风险增加了 50.7%。除肥胖外,同时患有 2 型糖尿病和高血压等伴发疾病会进一步增加动脉僵硬度,使心血管疾病的风险增加 35.1%。OBd 组和 Nd 组的 Aix 分别增加了 8.2%和 16.5%,但差异无统计学意义。Aix 与年龄、心率和主动脉收缩压直接相关。
黑人肥胖患者的 PWV 较高,表明动脉僵硬度增加,因此患心血管疾病的风险较高。此外,衰老、血压升高和 2 型糖尿病进一步导致这些肥胖患者的动脉僵硬。